This inventor holds 1 USPTO granted patent. Top assignee: Nissin Shokuhin Kabushiki Kaisha. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Kei Sugai: Innovator in Steroid Compounds
Introduction
Kei Sugai is a notable inventor based in Kawagoe, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of steroid compounds. His innovative work has led to the creation of a unique glycoside compound that has potential applications in medicine.
Latest Patents
Kei Sugai holds a patent for a 21-Substituted steroid compound. This glycoside is represented by a specific formula, wherein dexamethasone or betamethasone serves as the aglycon. The 21-position of the compound is substituted by a simple sugar or an acylated sugar selected from various types, including glucose, galactose, mannose, and others. This patent showcases his expertise in modifying steroid structures for enhanced functionality.
Career Highlights
Throughout his career, Kei Sugai has been associated with Nissin Shokuhin Kabushiki Kaisha, where he has contributed to various research projects. His work has been instrumental in advancing the understanding of steroid compounds and their applications in therapeutic settings.
Collaborations
Kei Sugai has collaborated with notable colleagues, including Motoaki Goto and Satoshi Yoshida. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kei Sugai's contributions to the field of steroid compounds highlight his role as an influential inventor. His patent for a 21-Substituted steroid compound exemplifies his innovative spirit and dedication to advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile